Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Effects of Creatine Formulations on Exercise and Cognitive Performance

10. listopadu 2026 aktualizováno: Terence Moriarty, University of Northern Iowa

Effects of Creatine Monohydrate Versus a Multi-Ingredient Creatine Formulation on Exercise Performance, Cognitive Function, Hydration, and Gastrointestinal Tolerability

This study will examine whether a multi-ingredient creatine supplement produces different effects on exercise performance, cognitive function, hydration, and gastrointestinal symptoms compared with creatine monohydrate alone.

Approximately 16 healthy, physically active adults aged 18-40 years will participate. Each participant will take creatine monohydrate (5 grams per day) for 18 days and a multi-ingredient supplement containing creatine monohydrate (5 grams), sodium, potassium, magnesium, and taurine for another 18 days. The order of supplementation will be randomly assigned, with a 30-day break between conditions.

Participants will complete laboratory testing before and after each supplementation period. Testing will include bench press exercise to assess muscular endurance, repeated high-intensity cycling tests to assess exercise performance, and a computerized cognitive task to measure attention and reaction time. Researchers will also assess hydration, selected blood markers, perceived exertion, and gastrointestinal symptoms.

The findings may help determine whether adding electrolytes and taurine to creatine provides additional benefits or produces different physiological responses compared with creatine monohydrate alone.

Přehled studie

Typ studie

Intervenční

Zápis (Odhadovaný)

16

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

Studijní místa

    • Iowa
      • Cedar Falls, Iowa, Spojené státy, 50614
        • Nábor
        • Wellness and Recreation Center
        • Kontakt:

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

18 let až 40 let (Dospělý)

Přijímá zdravé dobrovolníky

Ano

Pohlaví způsobilá ke studiu

Všechno

Popis

Inclusion Criteria:

  • Adults aged 18-40 years.
  • Apparently healthy individuals who are physically active and capable of performing vigorous exercise.
  • Willing and able to complete repeated maximal-intensity cycling tests, bench press exercise, and cognitive assessments.
  • Willing to consume both assigned dietary supplement formulations for 18 days each, separated by a 30-day washout period.
  • Willing to refrain from taking additional creatine or electrolyte supplements during the study, including the washout period.
  • Able and willing to provide written informed consent.

Exclusion Criteria:

  • History of cardiovascular, metabolic, renal, neurological, or musculoskeletal conditions that may contraindicate vigorous exercise or interfere with study outcomes.
  • Current injury or physical limitation that would prevent safe completion of the exercise testing procedures.
  • Current pregnancy or plans to become pregnant during the study.
  • Recent creatine supplementation prior to enrollment.
  • Current use of medications or dietary supplements that may interfere with creatine metabolism, hydration status, exercise performance, cognitive function, or participant safety.
  • Known allergy, intolerance, or contraindication to any ingredient in the study supplements.
  • Unwillingness or inability to comply with supplementation, washout, or laboratory testing requirements.

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Základní věda
  • Přidělení: Randomizované
  • Intervenční model: Crossover Assignment
  • Maskování: Trojnásobný

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Experimentální: Creatine Monohydrate Followed by Multi-Ingredient Creatine

Participants will receive creatine monohydrate (5 g/day) with sugar-free flavoring for 18 consecutive days, followed by a 30-day washout period. Participants will then receive a multi-ingredient formulation containing creatine monohydrate (5 g/day), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) for an additional 18 days. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after each supplementation period.

Participants will consume 5 g/day of creatine monohydrate mixed with sugar-free flavoring for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period.

Participants will consume a multi-ingredient dietary supplement containing creatine monohydrate (5 g), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) daily for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period.

Experimentální: Multi-Ingredient Creatine Followed by Creatine Monohydrate

Participants will receive a multi-ingredient formulation containing creatine monohydrate (5 g/day), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) for 18 consecutive days, followed by a 30-day washout period. Participants will then receive creatine monohydrate (5 g/day) with sugar-free flavoring for an additional 18 days. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after each supplementation period.

Participants will consume 5 g/day of creatine monohydrate mixed with sugar-free flavoring for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period.

Participants will consume a multi-ingredient dietary supplement containing creatine monohydrate (5 g), sodium (500 mg), potassium (250 mg), magnesium (50 mg), and taurine (1 g) daily for 18 consecutive days. On the final day of supplementation, the supplement will be consumed approximately 60 minutes before laboratory testing. Exercise performance, cognitive function, hydration status, physiological responses, and gastrointestinal tolerability will be assessed before and after the supplementation period.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Total Bench Press Repetitions
Časové okno: Baseline and Day 18 of each supplementation period.

Total number of repetitions completed across three sets of bench press exercise at 70% of baseline one-repetition maximum (1RM), performed to volitional fatigue with one minute of rest between sets.

Baseline and Day 18 of each supplementation period.
Peak Power During Repeated Wingate Tests
Časové okno: Baseline and Day 18 of each supplementation period.

Peak power output (watts) measured during three consecutive 30-second Wingate cycling tests, performed with standardized recovery periods.

Baseline and Day 18 of each supplementation period.
Mean Power During Repeated Wingate Tests
Časové okno: Baseline and Day 18 of each supplementation period.

Mean power output (watts) measured during each of three 30-second maximal-effort Wingate cycling tests.

Baseline and Day 18 of each supplementation period.
Total Work During Repeated Wingate Tests
Časové okno: Baseline and Day 18 of each supplementation period.

Total mechanical work (kilojoules) completed across three 30-second Wingate cycling tests.

Baseline and Day 18 of each supplementation period.
Stroop Interference Reaction Time
Časové okno: Day 1 and Day 18 of each 18-day supplementation period (three assessments per day).

Cognitive performance assessed using a computerized Stroop task completed before exercise and during recovery between repeated Wingate tests. Reaction time (milliseconds) will be used to evaluate changes in cognitive performance as exercise-induced fatigue accumulates.

Day 1 and Day 18 of each 18-day supplementation period (three assessments per day).
Stroop Task Accuracy
Časové okno: Day 1 and Day 18 of each 18-day supplementation period (three assessments per day).

Percentage of correct responses during a computerized Stroop task administered before exercise and during recovery between repeated Wingate cycling tests.

Day 1 and Day 18 of each 18-day supplementation period (three assessments per day).

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Wingate Fatigue Index
Časové okno: Baseline and Day 18 of each supplementation period.

Percentage decline in power output during repeated Wingate tests.

Baseline and Day 18 of each supplementation period.
Rating of Perceived Exertion
Časové okno: Baseline and Day 18 of each supplementation period.

Perceived exertion assessed using the Borg 6-20 scale following each Wingate.

Baseline and Day 18 of each supplementation period.
Blood Lactate Concentration
Časové okno: Baseline and Day 18 of each supplementation period.

Blood lactate concentration (mmol/L) measured following each Wingate.

Baseline and Day 18 of each supplementation period.
Urine Specific Gravity
Časové okno: Baseline and Day 18 of each supplementation period.

Urine specific gravity assessed before and after exercise to evaluate hydration status.

Baseline and Day 18 of each supplementation period.
Blood Sodium Concentration
Časové okno: Baseline and Day 18 of each supplementation period.

Sodium concentration measured using an i-STAT analyzer.

Baseline and Day 18 of each supplementation period.
Blood Potassium Concentration
Časové okno: Baseline and Day 18 of each supplementation period.

Potassium concentration measured using an i-STAT analyzer.

Baseline and Day 18 of each supplementation period.
Gastrointestinal Symptom Severity
Časové okno: Baseline and Day 18 of each supplementation period.

Daily 0-10 ratings of bloating, abdominal discomfort, nausea, diarrhea, constipation, reflux, and overall gastrointestinal discomfort.

Baseline and Day 18 of each supplementation period.

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Odhadovaný)

13. listopadu 2026

Primární dokončení (Odhadovaný)

31. května 2027

Dokončení studie (Odhadovaný)

31. května 2027

Termíny zápisu do studia

První předloženo

5. listopadu 2026

První předloženo, které splnilo kritéria kontroly kvality

10. listopadu 2026

První zveřejněno (Aktuální)

16. listopadu 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

16. listopadu 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

10. listopadu 2026

Naposledy ověřeno

1. listopadu 2026

Více informací

Termíny související s touto studií

Další identifikační čísla studie

  • IRB-FY27-58

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit